Relapsed/Refractory Transformed Follicular Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Transformed Follicular Lymphoma
| Record | Firm | Date |
|---|---|---|
| Axicabtagene Ciloleucel Expanded Access Study (NCT03153462) | Kite, A Gilead Company |
Track Relapsed/Refractory Transformed Follicular Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.